These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2554800)

  • 21. Cyclic cidofovir (cHPMPC) prevents congenital cytomegalovirus infection in a guinea pig model.
    Schleiss MR; Anderson JL; McGregor A
    Virol J; 2006 Mar; 3():9. PubMed ID: 16509982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus infection in immunocompromised guinea pigs: a model for testing antiviral agents in vivo.
    Aquino-de Jesus MJ; Griffith BP
    Antiviral Res; 1989 Nov; 12(4):181-93. PubMed ID: 2559656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Demonstration of cytomegalovirus and retrovirus pseudotypes in cultured guinea pig cells.
    Lerner-Tung MB; Crouch JY; Hsiung GD
    Virology; 1991 Feb; 180(2):826-30. PubMed ID: 1703374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Requirements for guinea pig cytomegalovirus tropism and antibody neutralization on placental amniotic sac cells.
    Choi KY; El-Hamdi NS; McGregor A
    J Gen Virol; 2020 Apr; 101(4):426-439. PubMed ID: 32068527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrastructural development and persistence of guinea pig cytomegalovirus in duet cells of guinea pig submaxillary gland.
    Fong CK; Bia F; Hsiung GD
    Arch Virol; 1980; 64(2):97-108. PubMed ID: 6247997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Replication-defective lymphocytic choriomeningitis virus vectors expressing guinea pig cytomegalovirus gB and pp65 homologs are protective against congenital guinea pig cytomegalovirus infection.
    Cardin RD; Bravo FJ; Pullum DA; Orlinger K; Watson EM; Aspoeck A; Fuhrmann G; Guirakhoo F; Monath T; Bernstein DI
    Vaccine; 2016 Apr; 34(17):1993-9. PubMed ID: 26973071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inclusion of the Viral Pentamer Complex in a Vaccine Design Greatly Improves Protection against Congenital Cytomegalovirus in the Guinea Pig Model.
    Choi KY; El-Hamdi NS; McGregor A
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31484753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Convalescent Immunity to Guinea Pig Cytomegalovirus Induces Limited Cross Strain Protection against Re-Infection but High-Level Protection against Congenital Disease.
    Choi KY; El-Hamdi NS; McGregor A
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study on the traditional Chinese medicine Jinyebaidu for prevention and treatment of intrauterine infection with guinea pigs cytomegalovirus.
    Chen S; Xiong J; Xing W; Wen L; Liu H; Wang X
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(6):721-3. PubMed ID: 16696337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytomegalovirus infection elicits a conserved chemokine response from human and guinea pig amnion cells.
    Putri DS; Berkebile ZW; Mustafa HJ; Fernández-Alarcón C; Abrahante JE; Schleiss MR; Bierle CJ
    Virology; 2020 Sep; 548():93-100. PubMed ID: 32838950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Placental Response to Guinea Pig Cytomegalovirus Depends Upon the Timing of Maternal Infection.
    Berkebile ZW; Putri DS; Abrahante JE; Seelig DM; Schleiss MR; Bierle CJ
    Front Immunol; 2021; 12():686415. PubMed ID: 34211475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of cytomegalovirus infection during pregnancy in guinea pig.
    Griffith BP; Lucia HL; Tillbrook JL; Hsiung GD
    J Infect Dis; 1983 Jun; 147(6):990-8. PubMed ID: 6304208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histopathologic and ultrastructural studies of disseminated cytomegalovirus infection in strain 2 guinea pigs.
    Fong CK; Lucia H; Bia FJ; Hsiung GD
    Lab Invest; 1983 Aug; 49(2):183-94. PubMed ID: 6308346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality.
    Swanson EC; Gillis P; Hernandez-Alvarado N; Fernández-Alarcón C; Schmit M; Zabeli JC; Wussow F; Diamond DJ; Schleiss MR
    Vaccine; 2015 Jul; 33(32):4013-8. PubMed ID: 26079615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low maternal CD4 count at inception of gestational cytomegalovirus (CMV) infection and impaired humoral response: effect on congenital CMV infection in the guinea pig.
    Harrison CJ; Burger R
    Clin Immunol Immunopathol; 1991 Aug; 60(2):171-80. PubMed ID: 1676941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rat cytomegalovirus-induced pneumonitis after allogeneic bone marrow transplantation: effective treatment with (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine.
    Stals FS; Zeytinoglu A; Havenith M; de Clercq E; Bruggeman CA
    Antimicrob Agents Chemother; 1993 Feb; 37(2):218-23. PubMed ID: 8383939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutralizing antibodies to gB based CMV vaccine requires full length antigen but reduced virus neutralization on non-fibroblast cells limits vaccine efficacy in the guinea pig model.
    Choi KY; El-Hamdi NS; McGregor A
    Vaccine; 2020 Feb; 38(10):2340-2349. PubMed ID: 32008881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of guinea pig cytomegalovirus DNA.
    Isom HC; Gao M; Wigdahl B
    J Virol; 1984 Feb; 49(2):426-36. PubMed ID: 6319742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravaginal cytomegalovirus (CMV) challenge elicits maternal viremia and results in congenital transmission in a guinea pig model.
    Olejniczak MJ; Choi KY; McVoy MA; Cui X; Schleiss MR
    Virol J; 2011 Mar; 8():89. PubMed ID: 21371319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of animal models to evaluate agents with potential activity against human cytomegalovirus.
    Kern ER
    Transplant Proc; 1991 Jun; 23(3 Suppl 3):152-5, discussion 155. PubMed ID: 1648821
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.